For Research Purposes Only. All products and information are intended exclusively for in vitro laboratory research. Not approved for human consumption. This content does not constitute medical advice and has not been evaluated by the FDA or COFEPRIS.
In growth hormone research, choosing between CJC 1295 with DAC vs without DAC is a decision that completely dictates the release pattern of the pituitary gland. While both compounds share a similar peptide core designed to stimulate Growth Hormone Releasing Hormone (GHRH) receptors, the presence of the Drug Affinity Complex (DAC) fundamentally alters the half-life and the biological "signature" of the compound.
Researchers must decide if their study requires the natural, pulsatile release of GH or a steady, elevated baseline. Here is what the clinical data shows.
The Role of GHRH in the Body
CJC-1295 is a tetrasubstituted 29-amino acid peptide analogue of GHRH. Its primary function in research models is to bind to the GHRH receptor in the anterior pituitary, triggering the secretion of Growth Hormone (GH). Unlike GHRPs (like Ipamorelin), which act on the ghrelin receptor, CJC-1295 mimics the body's natural signaling molecule to produce a cleaner GH release.
However, natural GHRH has a half-life measured in minutes. CJC-1295 was engineered with four amino acid substitutions to resist enzymatic degradation, extending that half-life to roughly 30 minutes. This is where the choice between CJC 1295 with DAC vs without DAC begins to matter.
What the DAC Actually Does
DAC stands for Drug Affinity Complex. It is a chemical addition (specifically a maleimide group) that allows the peptide to bind to albumin—the most abundant protein in the blood. By "hitchhiking" on albumin, the peptide avoids being filtered out by the kidneys or broken down by enzymes.
While the "No DAC" version (also known as Mod GRF 1-29) stays active for about 30 minutes, the version with DAC can remain active in the bloodstream for up to 8 days. This transforms the peptide from a short-lived pulse into a continuous, long-acting signal.
[Image comparing pulsatile vs sustained release hormone levels]
CJC 1295 With DAC vs Without DAC: Pulsatile vs Sustained Release
The core difference for any research protocol is the release rhythm.
- Without DAC (Pulsatile): This version creates a sharp spike in GH that mimics the natural pulses our bodies produce at night. It is typically researched for its ability to preserve the natural rhythm of the pituitary gland.
- With DAC (Sustained): This version creates "GH bleed." It keeps GH levels consistently elevated 24/7. While this can lead to higher overall IGF-1 levels, it eliminates the natural peaks and valleys of hormone secretion.
For researchers studying fat loss and cellular repair, the pulsatile release (No DAC) is often preferred to avoid "pituitary fatigue." However, for studies requiring maximum IGF-1 elevation with infrequent administration, the DAC version is the clinical standard.
Beyond Health Lab supplies both CJC-1295 With DAC 5mg and CJC-1295 No DAC 5mg at ≥99% verified purity. Every batch is HPLC tested to ensure your research data is accurate and reproducible.